2011
DOI: 10.1080/19488300.2010.550180
|View full text |Cite
|
Sign up to set email alerts
|

The structure of optimal statin initiation policies for patients with Type 2 diabetes

Abstract: Lipid abnormalities increase the risk of coronary heart disease (CHD) and stroke in patients with Type 2 diabetes. Statins can be used to treat these abnormalities, but may have adverse side effects. In this article, we consider the optimal timing of statin initiation for patients with Type 2 diabetes. We formulate an infinite-horizon Markov decision process to maximize the patient's quality-adjusted life years (QALYs) prior to the occurrence of the first CHD or stroke event. We describe the state of the proce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
4
3
2

Relationship

1
8

Authors

Journals

citations
Cited by 37 publications
(14 citation statements)
references
References 47 publications
0
13
0
1
Order By: Relevance
“…, T }. The model is based primarily on the work Hsih [2010] (with a few extensions) and also exhibits similarities to the ones described in Kurt et al [2011], Mason et al [2012], and Mason et al [2014]. Because diabetes is a chronic disease, its patients require long-term, personalized treatment plans that take into account a variety of factors, such as measures of blood glucose, negative side effects, and medical costs.…”
Section: Numerical Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…, T }. The model is based primarily on the work Hsih [2010] (with a few extensions) and also exhibits similarities to the ones described in Kurt et al [2011], Mason et al [2012], and Mason et al [2014]. Because diabetes is a chronic disease, its patients require long-term, personalized treatment plans that take into account a variety of factors, such as measures of blood glucose, negative side effects, and medical costs.…”
Section: Numerical Resultsmentioning
confidence: 99%
“…The optimal time for statin initiation, however, is a difficult medical problem due to the competing forces of health benefits and side effects. Kurt et al [2011] models the problem as an MDP with a value function monotone in a risk factor known as the lipid-ratio (LR). Finance…”
Section: Operations Researchmentioning
confidence: 99%
“…For certain problems, the IFR property together with some additional (and generally nonrestrictive) conditions guarantee an optimal threshold policy (see chapter 4 of Puterman [59] for a thorough discussion of this topic). These conditions have been used, for example, in the context of HIV (Shechter et al [65]), liver disease (Alagoz et al [2]), and type 2 diabetes (Kurt [44]) to prove the existence of an optimal control-limit policy under an ordering of states. A control-limit policy is one in which one action is optimal for all states below a certain threshold state (e.g., wait to transplant if the MELD score is below 25) and another action is optimal for all states at or above a certain value (e.g., transplant if the MELD score is at or above 25).…”
Section: Mdp and Pomdp Solution Methodsmentioning
confidence: 99%
“…Although screening for disease is one area of active research ("secondary prevention," as described in §3 above), there are many other areas of potential research that relate to chronic disease management. Specific examples include identification of high-risk geographical areas of disease (discussed below), optimizing treatment for cancer (Cao and Lim [13]), managing treatment for diabetic patients (Kurt et al [68], Mason et al [76], Shah et al [98]), evaluating treatment for patients with Alzheimer's (Craft et al [30]), preventing disease through early interventions, allocating resources between prevention and treatment (Alistar and Brandeau [2]), or allocating capacity for chronic care (Deo et al [36]). We describe work on two specific chronic diseases below.…”
Section: Chronic Diseasesmentioning
confidence: 99%